Untoward neonatal effect of intraamniotic administration of methylene blue (1976)

Peer-Reviewed Study · Cowett RM, Hakanson DO, Kocon RW, Oh W · July 1976

Cowett RM et al., 1976-07: Early case report of neonatal morbidity – hyperbilirubinemia from haemolysis – after intra-amniotic methylene blue was used to diagnose premature rupture of the membranes.

Hyperbilirubinemia secondary to hemolysis occurred in the newborn.

Cowett RM et al., 1976-07: Early case report of neonatal morbidity – hyperbilirubinemia from haemolysis – after intra-amniotic methylene blue was used to diagnose premature rupture of the membranes. C4 earliest primary neonatal harm report retrieved. Dose/route: intra-amniotic methylene blue injection (dose/concentration not stated in abstract). Funder/conflicts not stated. Comparator: none. The abstract is a single sentence plus this line; no abstract-level detail on outcome beyond hyperbilirubinemia. Study type: case report.